These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5537076)

  • 21. The effect of Lampren on human cells in culture.
    Delhanty JD; Attwood J; Wilkie D
    Br J Exp Pathol; 1974 Feb; 55(1):13-9. PubMed ID: 4835794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
    Vischer WA
    Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of phenazine dyes and N,N,N',N'-tetramethyl-p-phenylenediamine upon light-induced absorbance changes and photophosphorylation in Rhodospirillum rubrum extracts.
    Geller DM
    J Biol Chem; 1969 Feb; 244(3):971-80. PubMed ID: 5769193
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of neuritis in leprosy.
    Pfaltzgraff RE
    Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effective group of antihyaluronidase in blood].
    HUSZAK I; KONYVES-KOLONICS L; DOMONKOS J; TASS G
    Acta Physiol Acad Sci Hung; 1954; 6(1):1-9. PubMed ID: 13217831
    [No Abstract]   [Full Text] [Related]  

  • 26. B.663 and erythema nodosum leprosum.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
    [No Abstract]   [Full Text] [Related]  

  • 27. [Demonstration of the synergistic effect of prednisolone and oxyphenbutazone in the hyaluronidase-spreading-test in man].
    Mathies H; Uhl HC; Schneider P
    Arzneimittelforschung; 1967 Oct; 17(10):1297-300. PubMed ID: 5632881
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine.
    Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH
    Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084
    [No Abstract]   [Full Text] [Related]  

  • 29. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily).
    Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P
    Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082
    [No Abstract]   [Full Text] [Related]  

  • 31. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
    Hogerzeil LM
    Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early diagnosis, therapy, and research in the control of leprosy].
    Contreras Duenas F
    Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
    Morgan J
    Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute abdomen in a patient treated with lamprene.
    Jagadeesan K; Visweswaran MK; Iyer KH
    Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of leprosy with Lampren (B.663 Geigy).
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
    [No Abstract]   [Full Text] [Related]  

  • 36. Story behind the clinical trial of B.663 in leprosy.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduced number of peripheral blood granulocytes in chronic myeloid leukaemia during administration of clofazimine (B 663).
    Brandt L
    Scand J Haematol; 1972; 9(2):159-66. PubMed ID: 4504500
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyaluronidase, toluidine blue and blood coagulation].
    PELLEGRINI P; MODESTI G
    Boll Soc Ital Biol Sper; 1952 May; 28(5):966-8. PubMed ID: 13018575
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of sodium pyrocatecholcarboxylate on the spreading action of hyaluronidase towards dyes].
    LA BARRE J
    C R Seances Soc Biol Fil; 1956 Sep; 150(5):1018-9. PubMed ID: 13375015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.